Prostate Adenocarcinoma

Showing NaN - NaN of 15

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 20, 2023

Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Durvalumab
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 26, 2023

Localized Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Best Practice, Dietary Intervention, Exercise

Recruiting
  • Localized Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Best Practice
  • +4 more
  • Seattle, Washington
  • +1 more
Jan 9, 2023

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Laboratory Biomarker Analysis, Olaparib,

Active, not recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Laboratory Biomarker Analysis
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 19, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle

Active, not recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +7 more
  • Antiandrogen Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 23, 2022

Biochemically Recurrent Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • +6 more
  • Computed Tomography
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 7, 2022

Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Laboratory Biomarker Analysis, Quality-of-Life Assessment)

Terminated
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 28, 2021

Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC V7, Stage IIA Prostate Cancer AJCC v7 Trial in Seattle (Behavioral Dietary

Terminated
  • Prostate Adenocarcinoma
  • +2 more
  • Behavioral Dietary Intervention
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 8, 2021

Metabolic and Hormone Action on Plaque Formation in Brain and

Terminated
  • Prostate Adenocarcinoma
  • Evaluation
  • Quality-of-Life Assessment
  • Seattle, Washington
    Fred Hutch/University of Washington
Dec 8, 2020

Hormone-Resistant Prostate Cancer, Metastatic Prostatic Adenocarcinoma, Prostate Adenocarcinoma Trial in Portland, Seattle

Terminated
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Biopsy of Prostate
  • +3 more
  • Portland, Oregon
  • +2 more
Sep 19, 2019

Prostate Adenocarcinoma, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Seattle (drug, radiation, other)

Completed
  • Prostate Adenocarcinoma
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 21, 2018

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Canada, United States (drug,

Completed
  • Prostate Adenocarcinoma
  • +2 more
  • Fairbanks, Alaska
  • +169 more
Feb 23, 2018

Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (drug, other, procedure)

Completed
  • Prostate Adenocarcinoma
  • +4 more
  • Los Angeles, California
  • +14 more
Sep 18, 2017